Detalles de la búsqueda
1.
Circulating DNA in the neoadjuvant setting of early stage colon cancer.
Acta Oncol
; 61(10): 1223-1229, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35866544
2.
State of the art and future directions in the systemic treatment of neuroendocrine neoplasms.
Curr Opin Oncol
; 33(4): 378-385, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973550
3.
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
Acta Oncol
; 59(12): 1438-1446, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820683
4.
Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
World J Surg Oncol
; 18(1): 311, 2020 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33243287
5.
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
BMC Cancer
; 19(1): 134, 2019 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30744591
6.
Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.
HPB (Oxford)
; 20(7): 641-648, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29486918
7.
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
Eur J Nucl Med Mol Imaging
; 43(10): 1792-801, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27072811
8.
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.
Acta Oncol
; 60(4): 549-553, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435735
9.
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.
BMC Cancer
; 14: 385, 2014 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885112
10.
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.
J Nucl Med
; 65(2): 236-244, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164576
11.
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
BMC Cancer
; 13: 190, 2013 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23587148
12.
Targeted agents in older patients with gastrointestinal cancers - An overview.
J Geriatr Oncol
; 12(8): 1240-1252, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226158
13.
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.
Brain Commun
; 3(4): fcab220, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651126
14.
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Cancer Med
; 10(13): 4366-4374, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057299
15.
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Clin Colorectal Cancer
; 20(4): 326-333, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34404621
16.
Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
BMC Cancer
; 15: 173, 2015 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25879441
17.
PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
Cancer Lett
; 469: 142-150, 2020 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31669518
18.
Fat density is a novel prognostic marker in patients with esophageal cancer.
Clin Nutr ESPEN
; 39: 124-130, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859305
19.
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
BMJ Open Gastroenterol
; 7(1)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675198
20.
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
Clin Colorectal Cancer
; 19(4): 311-318.e1, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631787